Clariant
Market Cap
CHF5.1b
Last Updated
2020/03/28 21:19 UTC
Data Sources
Company Financials +
Executive Summary
Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells specialty chemicals worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet with reasonable growth potential.
Similar Companies
Share Price & News
How has Clariant's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLN's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
1.5%
CLN
2.9%
CH Chemicals
3.6%
CH Market
1 Year Return
-25.6%
CLN
7.6%
CH Chemicals
-6.9%
CH Market
Return vs Industry: CLN underperformed the Swiss Chemicals industry which returned 7.6% over the past year.
Return vs Market: CLN underperformed the Swiss Market which returned -6.9% over the past year.
Shareholder returns
| CLN | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.5% | 2.9% | 3.6% |
| 30 Day | -26.9% | -8.7% | -12.1% |
| 90 Day | -28.1% | -11.6% | -16.3% |
| 1 Year | -23.7%-25.6% | 10.9%7.6% | -2.2%-6.9% |
| 3 Year | -13.6%-17.6% | 30.9%21.6% | 11.6%0.5% |
| 5 Year | -13.4%-21.3% | 57.1%37.8% | 16.1%-2.9% |
Price Volatility Vs. Market
How volatile is Clariant's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Those Who Purchased Clariant (VTX:CLN) Shares A Year Ago Have A 27% Loss To Show For It1 month ago | Simply Wall St
Here's Why Clariant (VTX:CLN) Has A Meaningful Debt Burden1 month ago | Simply Wall St
What Kind Of Shareholders Own Clariant AG (VTX:CLN)?Valuation
Is Clariant undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CLN (CHF15.57) is trading below our estimate of fair value (CHF35.93)
Significantly Below Fair Value: CLN is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CLN is unprofitable, so we can't compare its PE Ratio to the Chemicals industry average.
PE vs Market: CLN is unprofitable, so we can't compare its PE Ratio to the Swiss market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CLN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CLN is good value based on its PB Ratio (2x) compared to the CH Chemicals industry average (3.6x).
Next Steps
Future Growth
How is Clariant forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
36.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.6%).
Earnings vs Market: CLN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CLN's is expected to become profitable in the next 3 years.
Revenue vs Market: CLN's revenue (3.5% per year) is forecast to grow faster than the Swiss market (2.4% per year).
High Growth Revenue: CLN's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLN's Return on Equity is forecast to be low in 3 years time (12%).
Next Steps
Past Performance
How has Clariant performed over the past 5 years?
-12.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLN is currently unprofitable.
Growing Profit Margin: CLN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CLN is unprofitable, and losses have increased over the past 5 years at a rate of -12.3% per year.
Accelerating Growth: Unable to compare CLN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.1%).
Return on Equity
High ROE: CLN has a negative Return on Equity (-1.27%), as it is currently unprofitable.
Next Steps
Financial Health
How is Clariant's financial position?
Financial Position Analysis
Short Term Liabilities: CLN's short term assets (CHF4.0B) exceed its short term liabilities (CHF2.7B).
Long Term Liabilities: CLN's short term assets (CHF4.0B) exceed its long term liabilities (CHF2.6B).
Debt to Equity History and Analysis
Debt Level: CLN's debt to equity ratio (77.4%) is considered high.
Reducing Debt: CLN's debt to equity ratio has reduced from 80.3% to 77.4% over the past 5 years.
Balance Sheet
Inventory Level: CLN has a high level of physical assets or inventory.
Debt Coverage by Assets: CLN's debt is covered by short term assets (assets are 1.9x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CLN has been profitable on average in the past, therefore cash runway is not a concern.
Forecast Cash Runway: CLN has been profitable on average in the past, therefore cash runway is not a concern.
Next Steps
Dividend
What is Clariant's current dividend yield, its reliability and sustainability?
3.53%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CLN's dividend (3.53%) is higher than the bottom 25% of dividend payers in the Swiss market (2.16%).
High Dividend: CLN's dividend (3.53%) is low compared to the top 25% of dividend payers in the Swiss market (4.34%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, CLN has been paying a dividend for less than 10 years.
Growing Dividend: CLN's dividend payments have increased, but the company has only paid a dividend for 8 years.
Current Payout to Shareholders
Dividend Coverage: CLN is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: CLN's dividends in 3 years are forecast to be covered by earnings (50.3% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.9yrs
Average board tenure
CEO
Clariant has no CEO, or we have no data on them.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.42yrs | CHF788.81k | 0.13% CHF6.7m | |
| Independent Lead Director | 0.67yr | CHF444.94k | 0.0061% CHF311.8k | |
| Independent Non-Executive Director | 9.17yrs | CHF309.02k | 0.020% CHF1.0m | |
| Independent Non-Executive Director | 3.92yrs | CHF360.00k | 0.0043% CHF218.5k | |
| Independent Non Executive Director | 11.92yrs | CHF337.42k | 0.012% CHF634.8k | |
| Independent Non Executive Director | 9.17yrs | CHF290.00k | 1.85% CHF94.7m | |
| Independent Non-Executive Director | 5yrs | CHF299.70k | 0.36% CHF18.3m | |
| Independent Non-Executive Director | 3.92yrs | CHF299.17k | 0.0046% CHF235.4k | |
| Independent Director | 1.42yrs | CHF295.69k | 0.00066% CHF33.8k | |
| Independent Vice Chairman | 2.17yrs | CHF345.03k | 0.00079% CHF40.5k |
3.9yrs
Average Tenure
60.5yo
Average Age
Experienced Board: CLN's board of directors are considered experienced (3.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Clariant AG's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Clariant AG
- Ticker: CLN
- Exchange: SWX
- Founded: 1886
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: CHF5.128b
- Shares outstanding: 329.35m
- Website: https://www.clariant.com
Number of Employees
Location
- Clariant AG
- Rothausstrasse 61
- Muttenz
- Basel-Landschaft
- 4132
- Switzerland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CLRN | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Jun 1995 |
| CLN | SWX (SIX Swiss Exchange) | Yes | Ordinary Shares | CH | CHF | Jun 1995 |
| 0QJS | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | CHF | Jun 1995 |
| CLRN | XTRA (XETRA Trading Platform) | Yes | Ordinary Shares | DE | EUR | Jun 1995 |
| CLZN.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Jun 1995 |
| CLZN.Y | OTCPK (Pink Sheets LLC) | ADR | US | USD | Oct 2008 | |
| CLRS | DB (Deutsche Boerse AG) | ADR | DE | EUR | Oct 2008 |
Biography
Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells specialty chemicals worldwide. It operates in four segments: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. The company offers flame retardants, performance additives, and advanced surface solutions for use in plastics, coatings, inks, and other applications; and catalysts for the petrochemical and refining, synthesis gas, chemical, emissions control, specialty zeolites and zeolite-based, and custom catalyst markets. It also provides bentonite based specialty products for the oil purification, foundry additive, desiccant, oxygen absorber, humidity, sediment management, civil engineering, waste water treatment, clay specialties, paper and detergent additive, PVC stabilizer, BTX-catalyst, and kerosene and jet fuel purification industries. In addition, the company offers industrial and consumer specialty chemicals and application solutions for the automotive brake fluid and coolant, aircraft anti-itching and deicing fluid, construction chemical, agrochemical, gas treatment, heat transfer fluid, home care, industrial and institutional cleaning, industrial lubricant additive, special solvent, paint and coating, and personal care and cosmetic ingredient markets. Further, it provides masterbatches for the agriculture, consumer goods, healthcare packaging, healthcare polymer solutions, packaging, fibers, and transportation markets; oil, mining, and refinery services to the oil and mining industries; and organic pigments, pigment preparations, and dyes for coatings, printing, plastics, consumer products, non-impact printing, and other special applications. Additionally, the company offers biotech and bio-based chemicals; electronic materials; food ingredients; VitiSpheres encapsulated active ingredients; and 3D printing filaments. Clariant AG was founded in 1886 and is headquartered in Muttenz, Switzerland.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/03/28 21:19 |
| End of Day Share Price | 2020/03/27 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.